- Conditions
- Pre-Eclampsia, Diphtheria, Tetanus and Pertussis Vaccine Reaction
- Interventions
- Tdap Vaccine Administration
- Drug
- Lead sponsor
- Institute of Arthritis Research
- Other
- Eligibility
- 18 Years to 42 Years · Female only
- Enrollment
- 1,600 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Idaho Falls, Idaho
Source: ClinicalTrials.gov public record
Updated Jun 15, 2020 · Synced May 22, 2026, 12:11 AM EDT